Search Articles — Sudonull

https://sudonull.com/google-i-o-2026-gemini-and-aluminium-os-change-the-rules

Google I/O 2026 Analytics: 900 million Gemini users, Docs Live, and Aluminium OS. Find out who loses from transactional AI. Detailed breakdown inside.

https://sudonull.com/neural-i-o-chip-replacing-copper-wires-with-microled-optics

Kopin and Fabric.AI are developing an optical Neural I/O chip for data transfer between GPUs using photons. Learn how this will change AI data centers and energy consumption.

https://sudonull.com/pid-controller-modeling-p-i-d-parts

Breakdown of PID controller via FDTD simulation of heater and mechanics. Code in Mathematica, error elimination, coefficient tuning. Study principles for embedded systems.

https://sudonull.com/stm32h723-sdr-receiver-i-q-on-16-bit-adc

Implementation of HF SDR 1–30 MHz on STM32H723ZGT6 with Tayloe mixer and DSP. Details of analog path, USB UAC1, standalone DAC. For middle/senior developers.

https://sudonull.com/ai-glasses-samsung-and-google-what-was-shown-at-i-o-2026

Analysis of the first demonstration of Intelligent Eyewear at Google I/O 2026: why Samsung and Google's AI glasses are dangerous for Meta. Agent functionality, design, and market forecast.

https://ymaho.com/meme-i-don-t-have-a-right-hand-story-of-viral-police-video

Video of a police officer who didn't understand a driver without a right hand became a meme. Watch how the phrase "I don't have a right hand" conquered the internet. Read the analysis.

https://ymaho.com/i-beauty-why-india-is-the-new-trend-in-skincare

Learn how Ayurveda and deals by giants like Estée Lauder are making India a leader in the global beauty industry. Detailed analysis of the I-Beauty trend.

https://ymaho.com/why-i-procrastinate-the-neuroscience-of-procrastination

Learn how your brain sabotages your plans. A scientific explanation of procrastination and 5 steps to combat it. Start taking action today!

https://ymaho.com/spac-aeon-acquisition-i-ipo-at-125m-acquisition-of-european-sports

SPAC Aeon Acquisition I conducted an IPO on Nasdaq at $125M to acquire European basketball. Analysis of the deal, risks, forecasts, and hidden insights for investors. Read more.

https://ymaho.com/fda-approved-first-gene-therapy-for-lad-i-in-children

FDA approved Kresladi (marnetegragene autotemcel) — the first stem cell gene therapy for children with severe LAD-I. Learn about the mechanism, precedents, and business model. Detailed analysis on the website.

https://ymaho.com/imp761-first-lag-3-agonist-passes-phase-i-in-autoimmune-diseases

Analysis of IMP761 data from Immutep at EULAR 2026: a new class of drugs for treating rheumatoid arthritis without total immunosuppression. Safety, mechanism, and prospects. Read more.

https://ymaho.com/marne-cel-fda-approval-gene-therapy-for-lad-i

FDA approved Marne-Cel for children with severe LAD-I: 100% survival in trials. Learn how Rocket Pharmaceuticals turned rejections into a breakthrough.

https://ymaho.com/car-t-therapy-for-ovarian-cancer-lira-cel-and-28-months-of-life

Updated Phase I data: CAR-T lira-cel showed 28-month survival in ovarian cancer. Learn why this is a breakthrough in solid tumor treatment.

https://ymaho.com/a-new-look-at-alzheimer-s-disease-roche-tests-spinal-aso-therapy

Roche has initiated Phase I trials of intrathecal ASO against ApoE for early Alzheimer's disease. Why this is a revolution, who will benefit, and hidden risks. Read the analysis.

https://ymaho.com/cd4-t-cells-kill-cancer-through-ferroptosis-a-breakthrough-in-immunology

Scientists have proven: CD4+ T lymphocytes destroy MHC I-negative tumors through ferroptosis. The discovery changes the approach to cancer immunotherapy and treatment of GVHD. Read the details.